These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 2577256
1. Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidism. Shong YK, Cho BY, Hong SK, Lee HK, Koh CS, Min HK. Korean J Intern Med; 1989 Jul; 4(2):118-24. PubMed ID: 2577256 [Abstract] [Full Text] [Related]
4. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease]. Chen W, Man N, Li YS, Shan ZY, Teng WP. Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113 [Abstract] [Full Text] [Related]
6. Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment. Cho BY, Shong YK, Chung JK, Lee MC, Lee HK, Koh CS, Min HK. Korean J Intern Med; 1990 Jan; 5(1):51-7. PubMed ID: 1980206 [Abstract] [Full Text] [Related]
10. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy. Ueta Y, Fukui H, Murakami H, Yamanouchi Y, Yamamoto R, Murao A, Santou Y, Taniguchi S, Mitani Y, Shigemasa C. Thyroid; 1999 Feb; 9(2):179-82. PubMed ID: 10090319 [Abstract] [Full Text] [Related]
12. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema. Cho BY, Shong YK, Lee HK, Koh CS, Min HK, Sohn I. Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255 [Abstract] [Full Text] [Related]
13. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases. Takasu N, Yamada T, Sato A, Nakagawa M, Komiya I, Nagasawa Y, Asawa T. Clin Endocrinol (Oxf); 1990 Dec; 33(6):687-98. PubMed ID: 1982861 [Abstract] [Full Text] [Related]
14. Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan. Tamaki H, Amino N, Kimura M, Hidaka Y, Takeoka K, Miyai K. J Clin Endocrinol Metab; 1990 Nov; 71(5):1382-6. PubMed ID: 1977757 [Abstract] [Full Text] [Related]
16. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment. Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A. Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255 [Abstract] [Full Text] [Related]
19. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy. Kung AW, Lau KS, Kohn LD. Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257 [Abstract] [Full Text] [Related]
20. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor. Watanabe Y, Tahara K, Hirai A, Tada H, Kohn LD, Amino N. Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]